🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Investigational Drug Acquiring Popularity Via Social Media

Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to contact these accounts directly for supplier links, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Separately, a robust market exists on messaging services, where communities with thousands of participants share “before and after” images, injection guides and assertions of next-day British shipping. Vendors market the substance there before directing customers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Experts Voice Worries

Nevertheless, doctors and chemists have cautions that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could result in individuals injecting products of unknown origin.

Several experts stated the demand for the experimental drug could be linked to the increasing cost of licensed slimming products such as Mounjaro.

Regulatory Status and Implementation

Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.

Service Reaction and Content Removal

Based on the social media company, the service has removed problematic content and banned associated keywords and query recommendations. The company stated it was committed to keeping the service safe and investing in enhancing compliance measures.

Digital Trading Operations

Research also discovered communities with up to 9,000 participants marketing the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up groups with numerous of users, populated with photos of weight loss, glowing testimonials and step-by-step instructions for mixing or administering at residence.

Within moments of entering one group, a seller posted WhatsApp details, where most purchases take place. The vendor provided an guidebook and promised delivery within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None inquired about body mass, medical conditions or previous experience.

Product Information and Pricing

Within these communities, messages display black plastic packages with postal service stickers, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with sterile water, or pre-filled pens usually priced at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A representative for Telegram said it regularly monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are administering materials they cannot confirm. Although the science behind this drug is sound, these digital products may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent cost increases for approved slimming medications such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.

Her team has already seen individuals harmed by self-injection from unverified sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These materials could be contaminated or improperly measured.”

Producer Statement

A representative from Eli Lilly said retatrutide was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a Lilly experimental product not yet authorized … may subject users to potentially significant health risks”.